ghavamiol

Ghavamiol is an experimental small molecule belonging to the class of n‑alkylpyrrolidines and pentoses. Its chemical formula is C9H18NO9S and it has a molecular weight of approximately 316.31 g/mol. Ghavamiol has not been approved for use in any country and there are no reported clinical trials or indications for this compound as of now. It is structurally related to carbohydrate derivatives and contains a pyrrolidine moiety with multiple hydroxyl groups and a sulfonate group. The mechanism of action is not fully characterized but it has been identified as interacting with alpha-mannosidase 2[5]. No further pharmacological or therapeutic information is available at this time[1][2][5].

Other names

(((3R)-4-((2R,3R,4R)-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-yl)-1,3-dihydroxybutan-2-yl)oxy)-lambda4-sulfanetris(olate){[(3R)-4-[(2R,3R,4R)-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-yl]-1,3-dihydroxybutan-2-yl]oxy}-lambda4-sulfanetris(olate)1'-((1,4-dideoxy-1,4-imino-D-arabinitol)-4-N-ammonium)-1'-deoxy-L-erythritol-3'-sulfate1'-((1,4-dideoxy-1,4-imino-L-arabinitol)-4-N-ammonium)-1'-deoxy-D-erythritol-3'-sulfate